Meyka Pro banner
Care Twentyone Corporation

Care Twentyone Corporation Fundamental Analysis (JPX: 2373.T)

2373.TJPX
HealthcareMedical - Care Facilities
¥403.00
¥0.00(0.00%)
Japanese Market opens in 17h 41m

Care Twentyone Corporation Fundamental Analysis (JPX: 2373.T)

Care Twentyone Corporation (JPX: 2373.T) shows weak financial fundamentals with a PE ratio of 51.86, profit margin of 0.21%, and ROE of 2.43%. The company generates $49.4B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position88.46%
PEG Ratio-0.61

Areas of Concern

ROE2.43%
Operating Margin2.28%
We analyze 2373.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 28.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
28.7/100

We analyze 2373.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

2373.T struggles to generate sufficient returns from assets.

ROA > 10%
0.33%

Valuation Score

Moderate

2373.T shows balanced valuation metrics.

PE < 25
51.86
PEG Ratio < 2
-0.61

Growth Score

Moderate

2373.T shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

2373.T shows balanced financial health with some risks.

Debt/Equity < 1
4.62
Current Ratio > 1
1.08

Profitability Score

Moderate

2373.T maintains healthy but balanced margins.

ROE > 15%
243.06%
Net Margin ≥ 15%
0.21%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 2373.T Expensive or Cheap?

P/E Ratio

2373.T trades at 51.86 times earnings. This suggests a premium valuation.

51.86

PEG Ratio

When adjusting for growth, 2373.T's PEG of -0.61 indicates potential undervaluation.

-0.61

Price to Book

The market values Care Twentyone Corporation at 1.31 times its book value. This may indicate undervaluation.

1.31

EV/EBITDA

Enterprise value stands at -3.60 times EBITDA. This is generally considered low.

-3.60

How Well Does 2373.T Make Money?

Net Profit Margin

For every $100 in sales, Care Twentyone Corporation keeps $0.21 as profit after all expenses.

0.21%

Operating Margin

Core operations generate 2.28 in profit for every $100 in revenue, before interest and taxes.

2.28%

ROE

Management delivers $2.43 in profit for every $100 of shareholder equity.

2.43%

ROA

Care Twentyone Corporation generates $0.33 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.33%

Following the Money - Real Cash Generation

Operating Cash Flow

Care Twentyone Corporation generates limited operating cash flow of $2.17B, signaling weaker underlying cash strength.

$2.17B

Free Cash Flow

Care Twentyone Corporation produces free cash flow of $2.03B, offering steady but limited capital for shareholder returns and expansion.

$2.03B

FCF Per Share

Each share generates $149.78 in free cash annually.

$149.78

FCF Yield

2373.T converts 37.04% of its market value into free cash.

37.04%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

51.86

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.61

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.31

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.62

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.08

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.02

vs 25 benchmark

ROA

Return on assets percentage

0.003

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How 2373.T Stacks Against Its Sector Peers

Metric2373.T ValueSector AveragePerformance
P/E Ratio51.8629.15 Worse (Expensive)
ROE2.43%492.00% Weak
Net Margin0.21%-11540.00% (disorted) Weak
Debt/Equity4.620.79 Weak (High Leverage)
Current Ratio1.085.18 Neutral
ROA0.33%-130.00% (disorted) Weak

2373.T outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Care Twentyone Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ